SLC6A19 and metabolic syndrome: In the context of the possible involvement of GPR142 in protecting against obesity/metabolic syndrome seen in SLC6A19-null mice, it is important to highlight that tryptophan and phenylalanine, the amino acid agonists for the receptor, are among the preferred substrates for SLC6A19.